Plain-English translation of NCT05607329 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether people with recurrent ovarian cancer benefit from having a second surgery to remove visible tumors before receiving , compared to receiving alone. The study focuses on patients whose cancer has returned after they completed maintenance treatment with a PARP inhibitor (a type of targeted therapy). Researchers want to understand whether this surgical approach, combined with , works better than by itself for this group of patients.
When ovarian cancer returns after PARP inhibitor maintenance treatment, doctors are not sure whether adding surgery before improves survival and quality of life. This trial aims to answer that question and help create clearer, evidence-based treatment guidelines for patients in this situation.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups: one group will undergo a second surgery to remove visible tumors, followed by , while the other group will receive alone. You will have imaging scans (like PET-CT) and blood tests before treatment to confirm you are eligible. Throughout the trial, you will have regular clinic visits to monitor your health, receive treatment, and assess how well the treatment is working. The trial will follow your progress over time to compare outcomes between the two treatment approaches.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
China